ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Agena Bioscience Granted EUA for High-Throughput SARS-CoV-2 Panel americanpharmaceuticalreview
November 05, 2020Agena Bioscience? announced its MassARRAY? SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA). -
Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel prnewswire
October 29, 2020Agena Bioscience? announced that its MassARRAY? SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted Emergency Use Authorization from the U.S. Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
